The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
WEZLANA ustekinumab 45 mg / 0.5 mL solution for subcutaneous injection vial (403012)
ARTG Name
WEZLANA ustekinumab 45 mg / 0.5 mL solution for subcutaneous injection vial
Product name
WEZLANA ustekinumab 45 mg / 0.5 mL solution for injection vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Sponsor
Ingredients
Ustekinumab
Licence category
RE
Licence status
A
Summary